Biovica International AB
556774-6150ActiveDeveloping blood tests to monitor cancer treatment efficacy.
Biotech Companybiovica.com
Yleiskatsaus
- 10–19
- Työntekijät
- 20–50milj SEK
- Liikevaihto
- 2009
- Perustettu
Avainpäättäjät
Rickard Boman
VP R&D and Production
Sofia Löhman
VP QA/RA
Anders Rylander
CEO
Fredrik Alpsten
Chair & Board Member – Audit Committee
+5 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Biovica International AB is a Swedish biotech company established in 2009. Its core mission is to transform cancer care management through innovative biomarker-based tests. The company specializes in developing and commercializing novel blood-based assays, such as the DiviTum® TKa test. This specifi...